Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now
Cerulean Pharma Inc. Common Stock Intraday Chart
|Intraday||Last 52 Weeks|
|High||$ 3.5618||$ 6.70|
|Low||$ 3.40||$ 1.82|
The current last sale of $3.44 is 89.01% Higher thanthe 52 week low.
Company Description (as filed with the SEC)
We are a clinical-stage, oncology-focused company applying our proprietary Dynamic Tumor Targeting(TM) Platform to develop differentiated therapies. We were incorporated under the laws of the State of Delaware on November 28, 2005 under the name Tempo Pharmaceuticals, Inc. In October 2008, we changed our name to Cerulean Pharma Inc. Our Dynamic Tumor Targeting Platform is designed to create nanoparticle-drug conjugates, or NDCs, with the aim of providing safer and more effective therapies for patients living with cancer. NDCs consist of anti-cancer therapeutics, or payloads, covalently linked to a proprietary polymer. An important goal for all drugs is to maximize the net clinical benefit by increasing the desired therapeutic effect while reducing adverse effects. This is especially difficult with drugs used to treat cancer, where the goal is to destroy or inhibit growth of cancer cells without damaging healthy cells. ... More ...
Where does CERU fit in the risk graph?
Nasdaq Official Price
|Annual EPS Est:||$-1.56|
|Quarterly EPS Est:||-0.42|